Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infections.

Literature DB >> 3293522

Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infections.

S M Finegold¹, H M Wexler.

Abstract

Mesh：

Substances：
Anti-Bacterial Agents

Year: 1988 PMID： 3293522 PMCID： PMC172239 DOI： 10.1128/AAC.32.5.611

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

20 in total

1. A preliminary report on the use of ceftizoxime vs. clindamycin/tobramycin for the therapy of intra-abdominal and pelvic infections.

Authors: G Harding; J Vincelette; A Rachlis; I Fong; L Mandell; R Feld; D Bailey
Journal: J Antimicrob Chemother Date: 1982-11 Impact factor: 5.790

2. Evaluation of ceftizoxime in acute peritonitis.

Authors: M A Lou; D F Chen; M Bansal; S Balasubramaniam; H Thadepalli
Journal: J Antimicrob Chemother Date: 1982-11 Impact factor: 5.790

3. Susceptibility testing of anaerobic bacteria.

Authors: S M Finegold; R D Rolfe
Journal: Diagn Microbiol Infect Dis Date: 1983-03 Impact factor: 2.803

Review 4. Factors affecting the choice of antimicrobial therapy for anaerobic infection.

Authors: G Cuchural; F P Tally
Journal: J Antimicrob Chemother Date: 1982-08 Impact factor: 5.790

Review 5. Comparative clinical trials in treatment of intra-abdominal sepsis.

Authors: S L Gorbach; K McGowan
Journal: J Antimicrob Chemother Date: 1981-12 Impact factor: 5.790

6. Imipenem/cilastatin in the treatment of intraabdominal infections: a review of worldwide experience.

Authors: L Kager; C E Nord
Journal: Rev Infect Dis Date: 1985 Jul-Aug

7. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.

Authors: G J Cuchural; F P Tally; N V Jacobus; S L Gorbach; K Aldridge; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe
Journal: Antimicrob Agents Chemother Date: 1984-08 Impact factor: 5.191

8. Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group.

Authors: F Lamothe; F Auger; J M Lacroix
Journal: Antimicrob Agents Chemother Date: 1984-05 Impact factor: 5.191

9. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess.

Authors: M E Levison; C T Mangura; B Lorber; E Abrutyn; E L Pesanti; R S Levy; R R MacGregor; A R Schwartz
Journal: Ann Intern Med Date: 1983-04 Impact factor: 25.391

10. Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections.

Authors: R L Sweet; M O Robbie; M Ohm-Smith; W K Hadley
Journal: Am J Obstet Gynecol Date: 1983-02-01 Impact factor: 8.661

12 in total

1. Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.

Authors: M Boeckh; H Lode; K M Deppermann; S Grineisen; F Shokry; R Held; K Wernicke; P Koeppe; J Wagner; C Krasemann
Journal: Antimicrob Agents Chemother Date: 1990-12 Impact factor: 5.191

2. In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.

Authors: K Lee; I H Jang; Y J Kim; Y Chong
Journal: Antimicrob Agents Chemother Date: 1992-01 Impact factor: 5.191

3. Effect of several antimicrobial agents on ciprofloxacin uptake by human neutrophils.

Authors: I García; A Pascual; E J Perea
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-03 Impact factor: 3.267

Review 4. Current antimicrobial therapy of anaerobic infections.

Authors: C V Sanders; K E Aldridge
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-11 Impact factor: 3.267

5. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.

Authors: L Dubreuil; J Breuil; A Dublanchet; A Sedallian
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-11 Impact factor: 3.267

6. Genetic and biochemical characterization of FUS-1 (OXA-85), a narrow-spectrum class D beta-lactamase from Fusobacterium nucleatum subsp. polymorphum.

Authors: Christine Voha; Jean-Denis Docquier; Gian Maria Rossolini; Thierry Fosse
Journal: Antimicrob Agents Chemother Date: 2006-08 Impact factor: 5.191